Tuesday 1 July | 10:07:37 Europe / Stockholm

Subscription

Calendar

Est. time*
2026-02-25 08:30 Year-end Report 2025
2025-10-23 08:00 Quarterly Report 2025-Q3
2025-08-14 08:00 Quarterly Report 2025-Q2
2025-06-16 - Annual General meeting
2025-05-15 - Ex-date Ordinary Dividend LIPUM 0.00 SEK
2025-04-24 - Quarterly Report 2025-Q1
2025-02-26 - Year-end Report 2024
2024-10-25 - Quarterly Report 2024-Q3
2024-08-09 - Quarterly Report 2024-Q2
2024-05-29 - Ex-date Ordinary Dividend LIPUM 0.00 SEK
2024-05-28 - Annual General meeting
2024-05-28 - Quarterly Report 2024-Q1
2024-04-02 - Extra General Meeting 2024
2024-02-29 - Year-end Report 2023
2023-10-31 - Quarterly Report 2023-Q3
2023-08-31 - Quarterly Report 2023-Q2
2023-06-27 - Extra General Meeting 2023
2023-05-11 - Ex-date Ordinary Dividend LIPUM 0.00 SEK
2023-05-10 - Annual General meeting
2023-04-25 - Quarterly Report 2023-Q1
2023-03-24 - Year-end Report 2022
2022-11-25 - Quarterly Report 2022-Q3
2022-10-12 - Extra General Meeting 2022
2022-07-27 - Quarterly Report 2022-Q2
2022-05-18 - Quarterly Report 2022-Q1
2022-04-27 - Ex-date Ordinary Dividend LIPUM 0.00 SEK
2022-04-26 - Annual General meeting
2022-03-25 - Year-end Report 2021
2021-12-22 - Extra General Meeting 2021
2021-11-26 - Quarterly Report 2021-Q3

Description

CountrySweden
ListFirst North Stockholm
SectorHealth care
IndustryDrugs & Trade
Lipum is a biopharmaceutical company. The company is in the clinical phase and specializes in the discovery and development of new treatments for chronic inflammatory diseases. The company's drug candidate is based on an antibody intended to be used in treatments to block a specific molecule in the immune system. The drug candidate is in the clinical phase with preclinical data for rheumatism. The company is also evaluating other inflammatory diseases. Lipum has its operations in Umeå.
2025-04-07 13:00:00

Tidigare datum för årsstämma för räkenskapsåret 2024 var den 14 maj 2025 men senareläggs nu till den 16 juni 2025.